Collagen-induced platelet shape change is not affected by positive feedback pathway inhibitors and cAMP-elevating agents

Silvia Riondino, Lavinia V. Lotti, Lucia Cutini, Fabio M. Pulcinelli

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Shape change is the earliest response of platelets to stimuli; it is mainly dependent upon Ca2+/calmodulin interaction subsequent to Ca 2+ mobilization and is mediated by myosin light chain kinase (MLCK) activation. It has been recently suggested that collagen itself is not able to elicit platelet shape change in the absence of ADP and thromboxane A2 costimulation but is capable of inducing MLCK activation. Since we hypothesize that the morphological changes of the few platelets that adhere to collagen might not be revealed by turbidimetry, the aim of this study was to assess platelet shape change using transmission electron microscopy, in the absence of the amplificatory feedback pathways of ADP and thromboxane A2. Our results demonstrated that only the platelets in contact with insoluble collagen fibers underwent a typical shape change, whereas those further away remained quiescent. Moreover, since cAMP enhances Ca2+ mobilization in response to collagen, in the present study, we also investigated whether cAMP is involved in the inhibition of collagen-induced platelet shape change and MLC phosphorylation. Platelets were thus treated with iloprost (28 nM) prior to stimulation. Electron microscopy studies demonstrated that iloprost did not modify collagen-induced shape change, whereas immunoblotting studies showed a slight inhibition of MLC phosphorylation in the presence of enhanced cAMP levels. We can thus conclude that collagen is able to cause platelet shape change through activation of Ca2+/calmodulin-dependent MLCK, without the involvement of amplificatory pathways. Enhanced cytosolic cAMP levels do not inhibit collagen-induced platelet shape change but exert a weak inhibitory action on MLCK.

Original languageEnglish
Pages (from-to)6504-6510
Number of pages7
JournalJournal of Biological Chemistry
Volume280
Issue number8
DOIs
Publication statusPublished - Feb 25 2005

Fingerprint

Platelets
Collagen
Blood Platelets
Feedback
Myosin-Light-Chain Kinase
Iloprost
Thromboxane A2
Phosphorylation
Chemical activation
Calmodulin
Adenosine Diphosphate
Nephelometry and Turbidimetry
Transmission Electron Microscopy
Immunoblotting
Electron microscopy
Electron Microscopy
Transmission electron microscopy
Fibers

ASJC Scopus subject areas

  • Biochemistry

Cite this

Collagen-induced platelet shape change is not affected by positive feedback pathway inhibitors and cAMP-elevating agents. / Riondino, Silvia; Lotti, Lavinia V.; Cutini, Lucia; Pulcinelli, Fabio M.

In: Journal of Biological Chemistry, Vol. 280, No. 8, 25.02.2005, p. 6504-6510.

Research output: Contribution to journalArticle

@article{da7b505229f244d48f4afe89fabdc6a6,
title = "Collagen-induced platelet shape change is not affected by positive feedback pathway inhibitors and cAMP-elevating agents",
abstract = "Shape change is the earliest response of platelets to stimuli; it is mainly dependent upon Ca2+/calmodulin interaction subsequent to Ca 2+ mobilization and is mediated by myosin light chain kinase (MLCK) activation. It has been recently suggested that collagen itself is not able to elicit platelet shape change in the absence of ADP and thromboxane A2 costimulation but is capable of inducing MLCK activation. Since we hypothesize that the morphological changes of the few platelets that adhere to collagen might not be revealed by turbidimetry, the aim of this study was to assess platelet shape change using transmission electron microscopy, in the absence of the amplificatory feedback pathways of ADP and thromboxane A2. Our results demonstrated that only the platelets in contact with insoluble collagen fibers underwent a typical shape change, whereas those further away remained quiescent. Moreover, since cAMP enhances Ca2+ mobilization in response to collagen, in the present study, we also investigated whether cAMP is involved in the inhibition of collagen-induced platelet shape change and MLC phosphorylation. Platelets were thus treated with iloprost (28 nM) prior to stimulation. Electron microscopy studies demonstrated that iloprost did not modify collagen-induced shape change, whereas immunoblotting studies showed a slight inhibition of MLC phosphorylation in the presence of enhanced cAMP levels. We can thus conclude that collagen is able to cause platelet shape change through activation of Ca2+/calmodulin-dependent MLCK, without the involvement of amplificatory pathways. Enhanced cytosolic cAMP levels do not inhibit collagen-induced platelet shape change but exert a weak inhibitory action on MLCK.",
author = "Silvia Riondino and Lotti, {Lavinia V.} and Lucia Cutini and Pulcinelli, {Fabio M.}",
year = "2005",
month = "2",
day = "25",
doi = "10.1074/jbc.M407854200",
language = "English",
volume = "280",
pages = "6504--6510",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "8",

}

TY - JOUR

T1 - Collagen-induced platelet shape change is not affected by positive feedback pathway inhibitors and cAMP-elevating agents

AU - Riondino, Silvia

AU - Lotti, Lavinia V.

AU - Cutini, Lucia

AU - Pulcinelli, Fabio M.

PY - 2005/2/25

Y1 - 2005/2/25

N2 - Shape change is the earliest response of platelets to stimuli; it is mainly dependent upon Ca2+/calmodulin interaction subsequent to Ca 2+ mobilization and is mediated by myosin light chain kinase (MLCK) activation. It has been recently suggested that collagen itself is not able to elicit platelet shape change in the absence of ADP and thromboxane A2 costimulation but is capable of inducing MLCK activation. Since we hypothesize that the morphological changes of the few platelets that adhere to collagen might not be revealed by turbidimetry, the aim of this study was to assess platelet shape change using transmission electron microscopy, in the absence of the amplificatory feedback pathways of ADP and thromboxane A2. Our results demonstrated that only the platelets in contact with insoluble collagen fibers underwent a typical shape change, whereas those further away remained quiescent. Moreover, since cAMP enhances Ca2+ mobilization in response to collagen, in the present study, we also investigated whether cAMP is involved in the inhibition of collagen-induced platelet shape change and MLC phosphorylation. Platelets were thus treated with iloprost (28 nM) prior to stimulation. Electron microscopy studies demonstrated that iloprost did not modify collagen-induced shape change, whereas immunoblotting studies showed a slight inhibition of MLC phosphorylation in the presence of enhanced cAMP levels. We can thus conclude that collagen is able to cause platelet shape change through activation of Ca2+/calmodulin-dependent MLCK, without the involvement of amplificatory pathways. Enhanced cytosolic cAMP levels do not inhibit collagen-induced platelet shape change but exert a weak inhibitory action on MLCK.

AB - Shape change is the earliest response of platelets to stimuli; it is mainly dependent upon Ca2+/calmodulin interaction subsequent to Ca 2+ mobilization and is mediated by myosin light chain kinase (MLCK) activation. It has been recently suggested that collagen itself is not able to elicit platelet shape change in the absence of ADP and thromboxane A2 costimulation but is capable of inducing MLCK activation. Since we hypothesize that the morphological changes of the few platelets that adhere to collagen might not be revealed by turbidimetry, the aim of this study was to assess platelet shape change using transmission electron microscopy, in the absence of the amplificatory feedback pathways of ADP and thromboxane A2. Our results demonstrated that only the platelets in contact with insoluble collagen fibers underwent a typical shape change, whereas those further away remained quiescent. Moreover, since cAMP enhances Ca2+ mobilization in response to collagen, in the present study, we also investigated whether cAMP is involved in the inhibition of collagen-induced platelet shape change and MLC phosphorylation. Platelets were thus treated with iloprost (28 nM) prior to stimulation. Electron microscopy studies demonstrated that iloprost did not modify collagen-induced shape change, whereas immunoblotting studies showed a slight inhibition of MLC phosphorylation in the presence of enhanced cAMP levels. We can thus conclude that collagen is able to cause platelet shape change through activation of Ca2+/calmodulin-dependent MLCK, without the involvement of amplificatory pathways. Enhanced cytosolic cAMP levels do not inhibit collagen-induced platelet shape change but exert a weak inhibitory action on MLCK.

UR - http://www.scopus.com/inward/record.url?scp=14844323609&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=14844323609&partnerID=8YFLogxK

U2 - 10.1074/jbc.M407854200

DO - 10.1074/jbc.M407854200

M3 - Article

C2 - 15598663

AN - SCOPUS:14844323609

VL - 280

SP - 6504

EP - 6510

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 8

ER -